PXINX
Price
$11.19
Change
-$0.07 (-0.62%)
Updated
Feb 21 closing price
Net Assets
1.3B
VTISX
Price
$142.02
Change
-$0.83 (-0.58%)
Updated
Feb 21 closing price
Net Assets
445.3B
Ad is loading...

PXINX vs VTISX

Header iconPXINX vs VTISX Comparison
Open Charts PXINX vs VTISXBanner chart's image
Impax International Sust Econ I
Price$11.19
Change-$0.07 (-0.62%)
VolumeN/A
Net Assets1.3B
Vanguard Total Intl Stock Idx Instl Sel
Price$142.02
Change-$0.83 (-0.58%)
VolumeN/A
Net Assets445.3B
PXINX vs VTISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PXINX vs. VTISX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXINX is a Buy and VTISX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 445B vs. PXINX (1.3B). VTISX pays higher dividends than PXINX: VTISX (3.32) vs PXINX (1.99). PXINX was incepted earlier than VTISX: PXINX (11 years) vs VTISX (9 years). PXINX is a more actively managed with annual turnover of: 56.00 vs. VTISX (4.00). PXINX has a lower initial minimum investment than VTISX: PXINX (1000) vs VTISX (3000000000). PXINX annual gain was more profitable for investors over the last year : 9.20 vs. VTISX (7.55). PXINX return over 5 years is better than : 31.39 vs. VTISX (19.79).
PXINXVTISXPXINX / VTISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD7.4936.374118%
Front LoadN/AN/A-
Min. Initial Investment100030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B445B0%
Annual Yield % from dividends1.993.3260%
Returns for 1 year9.207.55122%
Returns for 3 years17.636.01293%
Returns for 5 years31.3919.79159%
Returns for 10 years58.45N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSS0.940.02
+2.17%
DSS
ALEC1.870.01
+0.54%
Alector
SHOO38.23-0.47
-1.21%
Steven Madden Ltd
BCYC11.66-0.34
-2.83%
Bicycle Therapeutics plc
SMMT22.12-0.94
-4.08%
Summit Therapeutics